The cell and gene therapy market is evolving with a focus on developing treatments for larger patient populations. However, this growth poses challenges such as the need for specialized infrastructure and high treatment costs. As clinical benefits and cost-effectiveness become crucial factors, comparisons with traditional drugs are inevitable. In oncology, there is a transition from […]